Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman L Block

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Ebiomedicine|June 21, 2016
Grade-dependent Response to Finasteride in Early Prostate CancerFerenc G Rick, Norman L Block
Urology|February 6, 2009
Civilian gunshot injuries of the penis: the Miami experienceWolfgang H Cerwinka, Norman L Block
Indian Journal of Urology : IJU : Journal of the Urological Society of India|February 16, 2017
Genitourinary sarcoidosis: An essential review for the practicing clinicianNorman L Block, Bruce R Kava
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancersKaroly Szepeshazi, Norman L Block, Andrew V Schally
The Prostate|April 28, 2017
Discovery of LHRH and development of LHRH analogs for prostate cancer treatmentAndrew V Schally, Norman L Block, Ferenc G Rick
Oncotargets and Therapy|April 27, 2013
An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancerFerenc G Rick, Norman L Block, Andrew V Schally
The Journal of Urology|October 30, 2012
Re: editorial comment on LHRH antagonist cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia (Prostate 2011; 71: 736-747)Ferenc G Rick, Norman L Block, Andrew V Schally
Asian Journal of Andrology|June 27, 2015
New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormonesAndrew V Schally, Norman L Block, Ferenc G Rick
Expert Opinion on Pharmacotherapy|August 30, 2013
Agonists of luteinizing hormone-releasing hormone in prostate cancerFerenc G Rick, Norman L Block, Andrew V Schally
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 6, 2017
Expression of GHRH-R, a Potentially Targetable Biomarker, in Triple-negative Breast CancerMahsa Khanlari, Andrew V Schally, Norman L Block, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Ebiomedicine|June 21, 2016
Grade-dependent Response to Finasteride in Early Prostate CancerFerenc G Rick, Norman L Block
Urology|February 6, 2009
Civilian gunshot injuries of the penis: the Miami experienceWolfgang H Cerwinka, Norman L Block
Indian Journal of Urology : IJU : Journal of the Urological Society of India|February 16, 2017
Genitourinary sarcoidosis: An essential review for the practicing clinicianNorman L Block, Bruce R Kava
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancersKaroly Szepeshazi, Norman L Block, Andrew V Schally
The Prostate|April 28, 2017
Discovery of LHRH and development of LHRH analogs for prostate cancer treatmentAndrew V Schally, Norman L Block, Ferenc G Rick
Oncotargets and Therapy|April 27, 2013
An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancerFerenc G Rick, Norman L Block, Andrew V Schally
The Journal of Urology|October 30, 2012
Re: editorial comment on LHRH antagonist cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia (Prostate 2011; 71: 736-747)Ferenc G Rick, Norman L Block, Andrew V Schally
Asian Journal of Andrology|June 27, 2015
New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormonesAndrew V Schally, Norman L Block, Ferenc G Rick
Expert Opinion on Pharmacotherapy|August 30, 2013
Agonists of luteinizing hormone-releasing hormone in prostate cancerFerenc G Rick, Norman L Block, Andrew V Schally
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 6, 2017
Expression of GHRH-R, a Potentially Targetable Biomarker, in Triple-negative Breast CancerMahsa Khanlari, Andrew V Schally, Norman L Block, et al.
Pageof 9